期刊
NEUROBIOLOGY OF AGING
卷 33, 期 3, 页码 437-456出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2010.03.025
关键词
-
资金
- National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01 AG000950-06]
- Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/27, 442/2006]
- Swedish MFR
- MRC
- MRC [G0701075, MC_G1000735] Funding Source: UKRI
- Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish
- Medical Research Council [MC_G1000735, G0701075] Funding Source: researchfish
Alzheimer's disease (AD) is a complex disorder with a clear genetic component. Three genes have been identified as the cause of early onset familial AD (EOAD). The most common form of the disease, late onset Alzheimer's disease (LOAD), is, however, a sporadic one presenting itself in later stages of life. The genetic component of this late onset form of AD has been the target of a large number of studies, because only one genetic risk factor (APOE4) has been consistently associated with the disease. However, technological advances allow new approaches in the study of complex disorders. In this review, we discuss the new results produced by genome wide association studies, in light of the current knowledge of the complexity of AD genetics. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据